Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clingen PTEN Variant Curation Expert Panel, |
RCV000474539 | SCV002576571 | uncertain significance | PTEN hamartoma tumor syndrome | 2020-10-20 | reviewed by expert panel | curation | PTEN c.80-5C>T (IVS1-5C>T) is currently classified as a variant of uncertain significance for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). PM2: Absent in large sequenced populations |
Labcorp Genetics |
RCV000474539 | SCV000554533 | likely benign | PTEN hamartoma tumor syndrome | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001027126 | SCV001189632 | likely benign | Hereditary cancer-predisposing syndrome | 2022-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001027126 | SCV001360383 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001637034 | SCV001849872 | likely benign | not provided | 2019-08-08 | criteria provided, single submitter | clinical testing |